Depends on who you ask. The scoring for the primary endpoint is absent, mild, moderate, severe. In this context they may consider an average of going down one on the scale as clinically significant, they might consider it two, as compared to placebo. Using that parameter those (except diarrhea) which showed no clinical meaningful improvements may be because few patients exhibited those symptoms.